Saturday, January 15, 2011

CIRM: publications, not cures, the main product

The idea that scientific publications, not cures, are the principal product of California's CIRM got a further boost with CIRM's proposal to spend $600,000 over the next three years to start a new, online stem cell research journal.

One can find some discussion at
Three Bidders Seek California State Funds for Online Stem Cell Journal
which notes that the PLoS didn't bother to respond to CIRM's RFP:

The Public Library of Science, whose international headquarters are within walking distance of CIRM in San Francisco, did not submit a bid. The organization is “a nonprofit organization of scientists and physicians committed to making the world's scientific and medical literature a public resource.”

See also previous IPBiz post:

CIRM: publications, not cures, are the primary output

If hypothetically CIRM research is channeled solely into "for profit" journals, the result would diverge from the way the NIH handles things.

UPDATE. A review of a book by Cathryn Carson, "Heisenberg in the Atomic Age," begins with some text of use to scientists promoting CIRM:

In 1971, discussing the case for a new 300 GeV accelerator, Werner Heisenberg put his finger on the "difficult dilemma" faced by scientists who argue for financial support from the government. (...) "[I]t is essential that high-energy specialists be consulted as advisors, since only they can really judge the details. On the other hand, these specialists are necessarily also interested parties, since they or their students want to work at the giant accelerator."

331 Science 1012 (25 Feb 2011)


Post a Comment

<< Home